Live Breaking News & Updates on பிரீதிஜ்கேர் பள்ளி ஆஃப் மருந்து|Page 8

Stay updated with breaking news from பிரீதிஜ்கேர் பள்ளி ஆஃப் மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

COVID-19 cases in India underreported by over 20 million, study says

COVID-19 cases in India underreported by over 20 million, study says
Feb 5, 2021
Tests of antibodies, current infections reveal significant spread in India’s southern state
A new study, led by professors at the University of Chicago and Duke University, found that COVID-19 cases in the southern state of Karnataka, India, are nearly 95 times greater than reported.
The study led by Prof. Anup Malani from the University of Chicago’s Law School and Pritzker School of Medicine, and Prof. Manoj Mohanan from Duke University suggests that 44.1% of the population in rural areas and 53.8% in urban areas in the southern state of Karnataka tested positive for antibodies to COVID-19 by the end of August 2020. ....

United States , Manoj Mohanan , Anup Malani , Pritzker School Of Medicine , University Of Chicago , University Of Chicago Law School , Duke University , Journal Of The American Medical Association , Law School , Pritzker School , American Medical Association , Brena Freeman Professor , Covid 19 , Corona Virus , ஒன்றுபட்டது மாநிலங்களில் , மனோஜ் மோஹனன் , அனுப்பி மாழனி , பிரீதிஜ்கேர் பள்ளி ஆஃப் மருந்து , பல்கலைக்கழகம் ஆஃப் சிகாகோ , பல்கலைக்கழகம் ஆஃப் சிகாகோ சட்டம் பள்ளி , டியூக் பல்கலைக்கழகம் , இதழ் ஆஃப் தி அமெரிக்கன் மருத்துவ சங்கம் , சட்டம் பள்ளி , பிரீதிஜ்கேர் பள்ளி , அமெரிக்கன் மருத்துவ சங்கம் , கொரோனா வைரஸ் ,

Study: COVID-19 cases in India are nearly 95 times greater than reported

A new study, led by professors at the University of Chicago and Duke University, found that COVID-19 cases in the southern state of Karnataka, India, are nearly 95 times greater than reported. ....

Manoj Mohanan , Anup Malani , Emily Henderson , Pritzker School Of Medicine , University Of Chicago , University Of Chicago Law School , Duke University , Law School , Pritzker School , மனோஜ் மோஹனன் , அனுப்பி மாழனி , எமிலி ஹென்டர்சன் , பிரீதிஜ்கேர் பள்ளி ஆஃப் மருந்து , பல்கலைக்கழகம் ஆஃப் சிகாகோ , பல்கலைக்கழகம் ஆஃப் சிகாகோ சட்டம் பள்ளி , டியூக் பல்கலைக்கழகம் , சட்டம் பள்ளி , பிரீதிஜ்கேர் பள்ளி ,

Windtree Appoints Dr. Joseph Soffer to Lead Cardiovascular Clinical Development

Share this article
Share this article
WARRINGTON, Pa., Feb. 1, 2021 /PRNewswire/ Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced the appointment of Joseph Soffer, M.D., F.A.C.C., as Executive Director of Clinical Development, effective immediately.
We are thrilled to welcome Joe to lead our cardiovascular clinical development efforts at such an important time for Windtree, said Dr. Steve Simonson, Chief Medical Officer at Windtree Therapeutics. Joe s expertise in cardiology and substantial experience with drug development in the pharmaceutical industry will be invaluable to our istaroxime program in acute heart failure, including our study in early cardiogenic shock. ....

Joseph Soffer , Steve Simonson , Clinical Development At Glaxosmithkline , Affairs At Merck , Prnewswire Windtree Therapeutics Inc , Windtree Therapeutics Inc , Rutgers University , Pritzker School Of Medicine , University Of Chicago , Clinical Development , Executive Director , Chief Medical Officer , Internal Medicine , Senior Medical Director , Associate Medical Director , Medical Affairs , Pritzker School , Nasdaq Capital , Windtree Therapeutics , Incentive Plan , Nasdaq Listing Rule , ஜோசப் சோப்பேர் , ஸ்டீவ் சைமன்சன் , மருத்துவ வளர்ச்சி இல் கிளாக்சோஸ்மித்க்லைன் , வாழ்க்கைத்தொழில்கள் இல் மெர்க் , வின்ட்ரீ சிகிச்சை இன்க் ,

Spectrum Health appoints SVP of quality, safety and patient experience - Grand Rapids Business Journal

Grand Rapids Business Journal
Courtesy Spectrum Health
Spectrum Health West Michigan hired Dr. James Moses, M.D., MPH, as senior vice president of quality, safety and patient experience. He will begin his new role in April.
Moses comes to Spectrum Health from Boston University School of Medicine, Boston Medical Center, where he served as chief quality officer and vice president of quality and safety.
At Spectrum Health, Moses will develop and execute strategy, set targets and lead efforts for continuous improvement of quality, safety and patient experience. He will be responsible for integrating quality, safety and patient experience through collaborative leadership and targeted initiatives across Spectrum Health West Michigan. ....

United States , Boston University , Harvard School Of Public Health , Darryl Elmouchi , James Moses , Boston Medical Center , Boston Medical Center Clinical Learning Environment , Spectrum Health West Michigan , Boston University School Of Medicine , Boston Combined Residency Program , Master Of Public Health , Pritzker School Of Medicine , University Of Chicago , Spectrum Health , Boston University School , Spectrum Health West , Clinical Learning Environment Review , Chicago Pritzker School , Boston Children , Boston Medical , Public Health , Harvard School , ஒன்றுபட்டது மாநிலங்களில் , போஸ்டன் பல்கலைக்கழகம் , ஹார்வர்ட் பள்ளி ஆஃப் பொது ஆரோக்கியம் , ஜேம்ஸ் மோஸஸ் ,

Dynamic, personalized treatment approach may improve outcomes in gastroesophageal cancers

E-Mail
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls. The final results were published online on Jan. 21 in
Cancer Discovery, a journal of the American Association for Cancer Research.
Advances in technology have made it possible for scientists and physicians to use information about the genetic makeup of a cancerous tumor to inform cancer treatment, but genetic heterogeneity the genetic variation between cancers in different patients and even between tumors within the same patient can make it difficult to determine the most effective targeting strategy for treating individual patients. ....

United States , Kevin Roggin , D Kyle Hogarth , Daniel Catenacci , Eli Lilly , Samantha Lomnicki , Stephanie Moya , Mitchellc Posner , Theodore Karrison , Namrata Setia , Chih Yi Liao , Olivers Eng , Bryanf Peterson , Uzmad Siddiqui , Sunil Narula , Daiichi Sankyo , Lindsay Alpert , Murtuza Rampurwala , Natalie Reizine , Hedyl Kindler , Paul Chang , Kiran Turaga , Genentech Roche , John Hart , Foundation Medicine , Guardant Health ,